New Ingredients, New Life For Cytodyne’s Weight Loss Supplements
This article was originally published in The Tan Sheet
Executive Summary
A firm that has agreed to pay as much as $12.8 million to settle a false advertising complaint and that reorganized under bankruptcy protection after incurring losses from ephedra-related lawsuits is returning to the marketplace with a new weight loss supplement, according to a Jan. 15 announcement
You may also be interested in...
Supreme Court Refuses Ephedra Case, Battle Against Risk-Benefit Continues
Challenges to the risk-benefit analysis FDA applied in banning the use of ephedra will continue following the Supreme Court's May 14 refusal to hear Nutraceutical Corp.'s appeal, according to the firm's attorney and to industry trade groups
FTC Supplement Settlements Spotlight Bayer, Mark First Hoodia Action
Bayer "went too far" with weight-loss and -control claims for its One-A-Day WeightSmart product and violated a 1991 sanction the product's previous owner agreed to, the Federal Trade Commission said Jan. 4 when it announced a record $3.2 million fine against the consumer healthcare giant
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.